Screener
Immix Biopharma, Inc. IMMX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
FAQ
- What is Immix Biopharma, Inc.'s enterprise value?
- Immix Biopharma, Inc. (IMMX) reported enterprise value of $404.29M in Q1 2026.
- How has Immix Biopharma, Inc.'s enterprise value changed year-over-year?
- Immix Biopharma, Inc.'s enterprise value increased by 1174.9% year-over-year, from $31.71M to $404.29M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Immix Biopharma, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude